• A Real World Cost Analysis of Serum Hbsag Quantification Test in Patients with Chronic Hepatitis B- The Case of The University of Naples Federico II

    Nov 1, 2016, 00:00

  • Direct Cost Estimation of Psoriasis Treatment in Turkey- Results from a Delphi Panel

    Nov 1, 2016, 00:00

  • Comparison Between the EQ-5D-5l and the EQ-5D-3l for General Population in China

    Nov 1, 2016, 00:00

  • The Risks of Using Chinese Medications Associated with Cardiovascular Disease, Diabetes Mellitus, and Chronic Kidney Disease- A Systematic Review

    Nov 1, 2016, 00:00

  • Red and Processed Meat Intake Perception in the Portuguese Population- Association with the WHO Alert of 2015 – Preliminary Results of the Malert Study

    Nov 1, 2016, 00:00

  • A Review of the Use of Network Meta-Analysis In Nice Single Technology Appraisals

    Nov 1, 2016, 00:00

  • Long Term Outcome of Couples Undertaking their First IVF/ICSI Attempt- A French Study

    Nov 1, 2016, 00:00

  • Impact Of The Introduction Of New Branded Generic Equivalents On The Prescribing Patterns Of Anti-Dementia Medication

    Nov 1, 2016, 00:00

  • Estimation of The Budget Saving Potential Due To The Introduction of Benepali®, An Etanercept Biosimilar, For The Treatment of All Licensed Adult Etanercept Indications In Spain

    Nov 1, 2016, 00:00

  • Risk Sharing Agreements (RSA)- Exploratory Analysis of the Current Situation in Developed and Emerging Markets

    Nov 1, 2016, 00:00

  • Risk of Discontinuation of Advanced Therapy Medicinal Products Clinical Trials

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Dabigatran vs. Rivaroxaban and Vitamin K Antagonists in Elderly Patients with Nonvalvular Atrial Fibrillation in Spain

    Nov 1, 2016, 00:00

  • Developing A Small Cell Lung Cancer Conceptual Model to Inform Treatment Outcome and Assessment Strategy Decisions in Clinical Research

    Nov 1, 2016, 00:00

  • Assessment of Channelling Bias Among Initiators of Glucose Lowering Drugs - A Cohort Study

    Nov 1, 2016, 00:00

  • Market Access Agreements- What Impacts Drugs Purchasing in French Hospitals

    Nov 1, 2016, 00:00

  • A Qualitative Study Evaluating The Attitude and Perception of Physician and Pharmacist Towards Pharmacovigilance in Abbottabad, Pakistan

    Nov 1, 2016, 00:00

  • Pharmacoeconomic Analysis of Treatment of Adult Patients with Severe Uncontrolled Asthma with Omalizumab In Russia

    Nov 1, 2016, 00:00

  • Delays In Breast Cancer Diagnosis And Initiation of Treatment- Implementing The Pathways To Treatment Model In The Greek Setting

    Nov 1, 2016, 00:00

  • Treatment of Hypertension in Elderly - Pharmacoeconomic Evaluation

    Nov 1, 2016, 00:00

  • Economic Burden of Antibiotic-Resistant Nosocomial Gram-Negative Infections in Singapore Hospitals

    Nov 1, 2016, 00:00

  • Workload Analysis And Staffing Requirement Of Clinical Pharmacy Services At Ministry Of Health In Saudi Arabia

    Nov 1, 2016, 00:00

  • Epidemiological Profile of Knee Arthroplasty Surgery in Health Care System of Public Employees Located in Northeast Brazil Between July 2014 and December 2015

    Nov 1, 2016, 00:00

  • Role of Genetic Variation in Type Repeats of Histidine Rich Protein-2 Gene in Altering the Performance of Malaria Rapid Detection Kit in Global Context

    Nov 1, 2016, 00:00

  • Economic Study of Non-Pharmacological and Pharmacological Treatment for Osteoporosis Vertebral Fracture and Bone Events in Oncology Patients in a Health Insurance Provider in a Latin America Country

    Nov 1, 2016, 00:00

  • Estimating Study Costs For Use In Voi, A Study Of Dutch Publicly Funded Drug Related Research

    Nov 1, 2016, 00:00

  • Comparing the Hospitalization and Rehospitalization Expenditures of Myocardial Infarction Patients in Beijing, 2012-2013

    Nov 1, 2016, 00:00

  • A Cprd-Hes Database Study of Back Pain in the UK- Patient Pathways

    Nov 1, 2016, 00:00

  • Could European Regulators Contribute to Drug Budget Containment?

    Nov 1, 2016, 00:00

  • International Reference Pricing's Evolution In China

    Nov 1, 2016, 00:00

  • Is There a Threshold in France?- First Exhaustive Review of Published Health-Economic Appraisals by the Haute Autorite De Sante (HAS), (French National Authority for Health)

    Nov 1, 2016, 00:00

  • Health- Related Quality of Life in Diabetic People with Different Cardiovascular Risks

    Nov 1, 2016, 00:00

  • The Clinical, Functional and Economic Benefits of Physical Rehabilitation- A Systematic Review

    Nov 1, 2016, 00:00

  • The Public Health And Economic Impact Of Gender Neutral Quadrivalent Human Papillomavirus Vaccination Program In Brazil

    Nov 1, 2016, 00:00

  • The Potential Budget Impact of PCSK9 Inhibitors in Ireland

    Nov 1, 2016, 00:00

  • Association Between Body Mass Index Categories, Prevalence of Treated Type 2 Diabetes Mellitus, Total Healthcare Costs Among Patients Who Are Overweight or Obese

    Nov 1, 2016, 00:00

  • Gefitinib, Erlotinib and Chemotherapy as Second-Line Treatment for Patient with Advanced Non-Small Lung Cancer (NSCLC)

    Nov 1, 2016, 00:00

  • Comparative Efficacy and Saftey of Interventions in The Treatment of Advanced Soft Tissue Sarcoma- A Systematic Review and Network Meta Analysis

    Nov 1, 2016, 00:00

  • The Cost-Effectiveness Threshold in Cancer Therapy – is This A Good Idea?

    Nov 1, 2016, 00:00

  • Factors Affecting Pharmaceutical Expenditures- A Systematic Review

    Nov 1, 2016, 00:00

  • Developing a Comprehensive, Culturally Sensitive Conceptual Framework of Health Domains in Singapore

    Nov 1, 2016, 00:00

  • Evaluation Of The Clinical Characteristics And Economic Burden Of United States Veteran Patients Diagnosed With The Hepatitis C Virus

    Nov 1, 2016, 00:00

  • Pharmaceutical Policies In Eurasian Economic Union Countries

    Nov 1, 2016, 00:00

  • The Burden of Illness in Patients with Castrate-Resistant Prostate Cancer with Bone Metastases in Asia Pacific (Australia, South Korea, and Taiwan)

    Nov 1, 2016, 00:00

  • Cost-Minimization Analysis in Postoperative Pain Management After Non-Cardiac Major Surgeries in China- Parecoxib Versus Nonselective Nonsteroidal Anti-Inflammatory Drugs and Tramadol

    Nov 1, 2016, 00:00

  • A Conceptual Approach For Including Productivity Losses In Health Economic Evaluations From A Societal Viewpoint

    Nov 1, 2016, 00:00

  • Cost Of Illness Of Partial Onset Seizures Epilepsy In Italy- Results From The Prometeo Study

    Nov 1, 2016, 00:00

  • Do Scottish Formulary Decisions Match Recommendations Made By The Smc?

    Nov 1, 2016, 00:00

  • Innovative Contracting in Spain (2010-2016). Getting More "IN"

    Nov 1, 2016, 00:00

  • Analysis Of Expenditure In Multiple Sclerosis Disease Modifying Therapies Evolution Between 2004-2015 In Spain

    Nov 1, 2016, 00:00

  • Comparative Safety and effectiveness of Carbapenems Versus Alternative Antibiotics for Bacteraemia due to Enterobacteriaceae Producing Extended-Spectrum β-Lactamase in Empirical Therapy- A Systematic Review and Meta-Analysis

    Nov 1, 2016, 00:00

  • Pegaspargase In The Treatment of Acute Lymphoblastic Leukemia- A CMA Model Demonstrates Its Economic Benefit For The Italian National Health System

    Nov 1, 2016, 00:00

  • A Nationwide Survey on Infection Control Activities Within Hospitals Allowed to Implement Preferential Infection Prevention Countermeasure Fee in Japan

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis of Burns Management in Nigeria- A Case Study of National Orthopaedic Hospital, Enugu

    Nov 1, 2016, 00:00

  • Improving Patients Quality of Life By Valuation of Patient Satisfaction with Specific Characteristics of Medical Devices For Urinary Incontinence

    Nov 1, 2016, 00:00

  • Clinical Profile and Management of Chronic Kidney Disease in Indian Geriatric Patients at a Public Tertiary Care Hospital- A Cross-Sectional Study

    Nov 1, 2016, 00:00

  • Evaluation of Adherence To Management Guidelines of Asthmatic Patients In Greece And Measures To Implement To Achieve Asthma Control

    Nov 1, 2016, 00:00

  • A Cost-Effectiveness Analysis of Biosimilar Infliximab (Inflectra ®) For The Treatment of Ankylosing Spondylitis In Nine European Countries

    Nov 1, 2016, 00:00

  • Rapid, Comprehensive Oral Nutritional Supplement Quality Improvement Program Reduces Length Of Stay In Malnourished Hospitalized Patients

    Nov 1, 2016, 00:00

  • The Cost-Effectiveness of Sacubitril/Valsartan for The Treatment of Chronic Heart Failure with Reduced Ejection Fraction in Alternative Age Groups

    Nov 1, 2016, 00:00

  • Assessment of Health Related Quality of Life of Hospital Admitted Patients in Tertiary Care Hospitals Quetta by Using SF-12 Questionnaire

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Liraglutide 1.8Mg Versus Lixisenatide 20μg for Patients with Type 2 Diabetes Mellitus in Italy

    Nov 1, 2016, 00:00

  • What Matters Most? An Exploration of Decision Criteria Considered by Patients with GEP-NET and Physicians Using Holistic Multi-Criteria Decision Analysis

    Nov 1, 2016, 00:00

  • Measurement of Utilities by Time to Death Related to Advanced Non-Small Cell Lung Cancer in South Korea

    Nov 1, 2016, 00:00

  • A Multi-Criteria Decision Analysis Approach within The Diabetic Macular Edema Field- The Experience of 3 Italian Regions

    Nov 1, 2016, 00:00

  • International Reference Pricing- Measuring Country Influence

    Nov 1, 2016, 00:00

  • Refining The Path to Personalized Medicine with Psychometric Analysis of Oral Cancer Biomarkers

    Nov 1, 2016, 00:00

  • Burden of Early and Advanced Breast Cancer in The Netherlands

    Nov 1, 2016, 00:00

  • Comparing Different Data on Disease Burden In Multiple Sclerosis

    Nov 1, 2016, 00:00

  • The Potential Public Health Impact of Varicella Vaccination in Hungary

    Nov 1, 2016, 00:00

  • Treatment Pattern Differences Across the United States, Western Europe, and Japan Among Patients with Metastatic Renal Cell Carcinoma

    Nov 1, 2016, 00:00

  • Quality of Life in Relapsing Remmiting Multiple Sclerosis- Influence of Interferon Beta-1a (Avonex And Cinnovex) Treatment

    Nov 1, 2016, 00:00

  • The Study of Drug Price Comprison Between China and 14 Other Countries

    Nov 1, 2016, 00:00

  • Toward A New Business Model for Biosimilars

    Nov 1, 2016, 00:00

  • Patterns of Medication Regimen Complexity Over One-Year Follow Up in Chronic Obstructive Pulmonary Disease Patients

    Nov 1, 2016, 00:00

  • Cost Effectiveness Analysis of Sofosbuvir and Ledipasvir/Sofosbuvir in Hepatitis C Virus (HCV) Patients

    Nov 1, 2016, 00:00

  • Treatment Patterns of Patients Treated With Ranibizumab or Aflibercept For The Management of Neovascular Age-Related Macular Degeneration- A Retrospective Cohort Study in Australia

    Nov 1, 2016, 00:00

  • The Impact of Age- And Gender- Differences In Direct Hospitalization Costs for Hemorrhagic Stroke In-Patients with Basic Medical Insurance Scheme For Urban Residents of China

    Nov 1, 2016, 00:00

  • Cost-Minimization Analysis of Lipegfilgrastim in Prophylaxis Of Febrile Neutropenia in Cancer Patients

    Nov 1, 2016, 00:00

  • Ticagrelor Treatment for Prevention of Cardiovascular Events in High Risk Post Myocardial Infarction Patients- Cost-Effectiveness Analysis Using Evidence From The Pegasus-Timi 54 Trial

    Nov 1, 2016, 00:00

  • Healthcare Resource use of Patients Newly Diagnosed with Multiple Sclerosis Initiating Oral or Self-Injectable Disease-Modifying Drugs- A Large, Nationwide Analysis of US Electronic Health Record Data

    Nov 1, 2016, 00:00

  • Fixed-Dose Combination Drugs Undergoing Amnog - Learnings from 5 Years

    Nov 1, 2016, 00:00

  • A Systematic Review of Treatment Patterns in Patients with Recurrent Glioblastoma in the Real World

    Nov 1, 2016, 00:00

  • Network Meta-Analysis To Evaluate The Efficacy of Ixekizumab In The Treatment of Moderate-To-Severe Psoriasis

    Nov 1, 2016, 00:00

  • Results of A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of The Efficacy And Safety of Sirukumab, An Anti-IL-6 Cytokine Monoclonal Antibody, In Patients with Active Rheumatoid Arthritis Despite Disease-Modifying Anti-Rheumat ...

    Nov 1, 2016, 00:00

  • Effectiveness Factors In HTA Reports Concerning Type 2 Diabetes

    Nov 1, 2016, 00:00

  • A Cost-Utility Analysis of Different Antiviral Medicine Regimens in Patients with Chronic Hepatitis C Virus Genotype 1 in Iran

    Nov 1, 2016, 00:00

  • The Reduction Of Ceiling With The Eq-5d-5l Increases With Age In The General Adult Population

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Apixaban and Enoxaparin for Prevention of Venous Thromboembolism After Total Knee Replacement in China

    Nov 1, 2016, 00:00

  • A Regional Analysis of Relapsing Remitting MS (RRMS) Patients Treated with Natalizumab Suggests a Need to Diagnose and Treat Early in Latin Americans

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Regorafenib for The Treatment in Third and Fourth Lines of Metastasic Colorectal Cancer in Spain

    Nov 1, 2016, 00:00

  • How Does Health Technology Assessment of Personalized Medicine for Non-Small Cell Lung Cancer Differ in France, Germany, and England?

    Nov 1, 2016, 00:00

  • Health Economics Analysis Plans- Where Are We Now?

    Nov 1, 2016, 00:00

  • Factors Associated with the Use of Complementary Medicines in Hypertension

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of A Flash Glucose Monitoring System for Patients with Diabetes Who Are Using Intensive Insulin

    Nov 1, 2016, 00:00

  • The 2016 US Payor Landscape- Results from a Survey of Medical and Pharmacy Directors on Formulary Management

    Nov 1, 2016, 00:00

  • An Updated Cost-Effectiveness Analysis of Synflorix Universal Mass Vaccination Implementation in New Zealand

    Nov 1, 2016, 00:00

  • Antipsychotic Drug Prescribing, Cost of Treatment, Adverse Drug Reaction Monitoring, And Quality of Life Assessment in Outpatients of a Tertiary Care Hospital in Delhi

    Nov 1, 2016, 00:00

  • Effects of Medical Marijuana Legalization on Marijuana Use Among Adolescents and Adults In The United States

    Nov 1, 2016, 00:00

  • Current Practice and Attitude Regarding off-Label Drug Use- A Survey of Oncology Practitioners

    Nov 1, 2016, 00:00

  • Infertility Treatment Of Women Over Age 35 In Brazil- An Economic Evaluation Of Recombinant VS. Urinary Gonadotropins

    Nov 1, 2016, 00:00

  • Association of Socioeconomic Conditions and Drug Offences and Reincarceration

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Once-Yearly Injection of Zoledronic Acid For The Treatment of Osteoporosis In Japan

    Nov 1, 2016, 00:00

  • Hospitalized Patients with Schizophrenia In Portugal- Clinical Characterization and Costs

    Nov 1, 2016, 00:00

  • Estimating Utilities for Liver Diseases Using Standard Gamble Method

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Pembrolizumab in Patients with Advanced Melanoma Previously Treated with Ipilimumab in Portugal

    Nov 1, 2016, 00:00

  • Which costs matter? Costs included in economic evaluation and their impact on decision uncertainty- the example of acute myocardial infarction

    Nov 1, 2016, 00:00

  • Impact of Comorbidities on the Cost of Depression Drug Therapy in General Practices in Germany

    Nov 1, 2016, 00:00

  • Temporal Trends In Transthyretin Familial Amyloid Polyneuropathy Natural Survival Over A Century

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Test Strips for Glucose Monitoring

    Nov 1, 2016, 00:00

  • Comparative Effectiveness Analysis for Smoking Cessation Medications

    Nov 1, 2016, 00:00

  • Screening Rate for Diabetic Retinopathy and Macular Edema in Patients with Diabetes and their Treatment Costs in the United Arab Emirates

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Sacubitril/ Valsartan in Chronic Heart Failure with Reduced Ejection Fraction in The Czech Republic- Analysis Based on Patient Characteristics From Randomized Clinical Trial and Local Registries

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Ideglira Versus Basal-Bolus Insulin Intensification Regimens in Patients with Type 2 Diabetes in Slovak Setting

    Nov 1, 2016, 00:00

  • Global Value Dossiers (GVDS)- How to Ensure the Value Isn’t Lost in Translation

    Nov 1, 2016, 00:00

  • The Burden of Staple Line Interventions in Colorectal Surgery Europe

    Nov 1, 2016, 00:00

  • Meta-Analysis of The Effectiveness on Peginterferon for Chronic Hepatitis C

    Nov 1, 2016, 00:00

  • Burden of Childhood Onset Chronic Kidney Disease

    Nov 1, 2016, 00:00

  • Economic Evaluation of First Line Treatment for Advanced Non Small Cell Lung Cancer Using Tyrosine Kinase Inhibitors in Malaysia

    Nov 1, 2016, 00:00

  • Comparative Effectiveness of Carbapenems Versus Alternative Antibiotics for the Treatment of Bacteraemia Due to Enterobacteriaceae Producing Extended-Spectrum β-Lactamase in Definitive Therapy- A Systematic Review and Meta-Analysis

    Nov 1, 2016, 00:00

  • Real-World Comparing Intravenous Busulfan to Total Body Irradiation in Hematopoietic Stem Cell Transplantation aith a Japanese Diagnosis Procedure Combination (DPC) Database

    Nov 1, 2016, 00:00

  • Cost Assessment of Implementation of Immune Tolerance Induction in Kmc Hospital

    Nov 1, 2016, 00:00

  • Economic Burden of Primary Immunodeficiency (PIDD) In Turkey

    Nov 1, 2016, 00:00

  • The Impact Of Policy And Demographic Variables On Future Prescription Costs For A Publicly Funded Health Scheme In Ireland

    Nov 1, 2016, 00:00

  • Dengue Negatively Affects Gdp And Federal Revenues In Endemic Areas Of Mexico

    Nov 1, 2016, 00:00

  • A Discussion on Coping- Translation of the Eular Psoriatic Arthritis Impact of Disease- Psaid-9 for Clinical Trials in 19 Languages for 18 Countries

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Nepafenac 3 Mg/Ml for the Reduction in Risk of Post-Operative Macular Oedema Associated with Cataract Surgery- From UK NHS Perspective

    Nov 1, 2016, 00:00

  • Review of National Health Technology Assessment Reports on Treatment of Severe Haemophilia A

    Nov 1, 2016, 00:00

  • Assessing The Cost Saving Potential of Introducing Benepali®, An Etanercept Biosimilar, For The Treatment of All Licensed Adult Etanercept Indications In France, Italy And Sweden

    Nov 1, 2016, 00:00

  • Follow-Up Imaging After Nephrectomy in Canada- Urologists’ Compliance with Guidelines and Cost of Surveillance

    Nov 1, 2016, 00:00

  • Economic Aspects in the Treatment of Schizophrenia in Italy- Cost Consequences of an Early Long-Acting Injectable Antipsychotics (LAIS) Approach

    Nov 1, 2016, 00:00

  • High-Risk Medications and Unplanned Hospitalizations- A Case–Time–Control Study

    Nov 1, 2016, 00:00

  • Price Negotiations for Orphan Drugs in Germany

    Nov 1, 2016, 00:00

  • Health Economic Evaluation of Watchmantm Left Atrial Appendage Closure (LAAC) Device Vesus Long-Term Warfarin Therapy in Patients with Atrial Fibrillation (AF) in China

    Nov 1, 2016, 00:00

  • Use of Antihypertensive Medications in Diabetic and Non-Diabetic Chronic Kidney Disease and Hemodialysis Patients- A Due Study

    Nov 1, 2016, 00:00

  • New Approach to Budget Impact Analysis - Ibrutinib In Treatment of Relapsed/Refractory Cll Patients in The Czech Republic

    Nov 1, 2016, 00:00

  • community Residents' Knowledge and Attitudes Towards Antibiotics in Penang, Malaysia- A Cross-Sectional Study

    Nov 1, 2016, 00:00

  • Mental Health - Costs and Treatment Penetration Across Europe

    Nov 1, 2016, 00:00

  • Direct Cost Analysis and Cost Effectiveness Analysis of Chronic Obstruction Pulmonary Disease in Fatmawati Public Hospital

    Nov 1, 2016, 00:00

  • Analyzing a German Index for the EQ-5D-5L Based on Experienced Health

    Nov 1, 2016, 00:00

  • Comparative Analysis on The Out-Of-Pocket Expenditure Among Patients Suffering From Chronic Kidney Disease between Medical Insurance Covered And Uncovered Areas in China

    Nov 1, 2016, 00:00

  • Patient Engagement- To Support Medication Adherence in Kidney Transplantation

    Nov 1, 2016, 00:00

  • Knowledge, Attitude and Perception of Japanese Encephalitis Among Healthcare Students of Medicine, Pharmacy and Dentistry of A Private University in Malaysia

    Nov 1, 2016, 00:00

  • Linguistic Validation and Electronic Migration of the Kansas City Cardiomyopathy Questionnaire (KCCQ)

    Nov 1, 2016, 00:00

  • Implementation of Medication Errors Reporting System by Clinical Pharmacists at Tertiary Care Teaching Hospital- A Pilot Study

    Nov 1, 2016, 00:00

  • Economic Evaluation of Olaparib In Patients with Brca – Mutated Psroc in Greece

    Nov 1, 2016, 00:00

  • The Organisational Analysis of “Patient Diagnostic Therapeutic Pathway” For Patients with Gastric Cancer In 5 Centres of The Veneto Region (Italy)

    Nov 1, 2016, 00:00

  • Analysis of the Asco Value Framework Net Health Benefit Score as A Tool for Assessing Novel Therapies in Relapsed/Refractory Multiple Myeloma (Rrmm)

    Nov 1, 2016, 00:00

  • The Validity of Markov Model for the Prognostic Estimation of Chronic Kidney Disease

    Nov 1, 2016, 00:00

  • Economic Impact of Rivaroxaban use for Thromboembolic Events Prevention After HIP or Knee Replacement in Spain

    Nov 1, 2016, 00:00

  • A Conceptual Framework for Tackling Market Access Challenges in Asia

    Nov 1, 2016, 00:00

  • Cardiovascular Event Rates in Patients with High Cardiovascular Risk in the United Kingdom

    Nov 1, 2016, 00:00

  • Impact of Empagliflozin (Jardiance) to the NHS- Estimation of Budget and Event Impact Based on Empa-Reg Outcome Data

    Nov 1, 2016, 00:00

  • Forecasting Lifetime Health Outcomes and Costs of Treatment for Non-Alcoholic Fatty Liver Disease

    Nov 1, 2016, 00:00

  • Healthcare Resource Utilization in Patients Receiving Pembrolizumab or Docetaxel with Previously Treated Advanced NSCLC

    Nov 1, 2016, 00:00

  • Oncologists` Views on Reimbursement and Value of Cancer Drugs in Bosnia and Herzegovina

    Nov 1, 2016, 00:00

  • Excess Costs of Panic Disorder with or without Agoraphobia in Germany - The Application of Entropy Balancing to Multiple Imputed Datasets

    Nov 1, 2016, 00:00

  • Could Amnog Become Irrelevant in the 21st century? Potential Redundancies in The Amnog Process in the ERA of Curative Therapies

    Nov 1, 2016, 00:00

  • Assessing The Potential Cost Saving Potential of Implementing Benepali®, An Etanercept Biosimilar, Using Discount Agreements For The Treatment of All Licensed Etanercept Indications For Adults In Sweden

    Nov 1, 2016, 00:00

  • Gefitinib, Erlotinib or Afatinib for EGFR Mutated NSCLC patients? A Meta-Analysis and Indirect Comparison on the Efficacy of First-Line Tyrosine Kinase Inhibitors

    Nov 1, 2016, 00:00

  • Clinical and Economic Impact of The Use Of Infliximab Biosimilar Inflectra In Rheumatoid Arthritis, Psoriatic Arthropathy And Ankylosing Spondylitis Patients

    Nov 1, 2016, 00:00

  • Assessment of Medication Adherence and The Associated Cost of Calendar Blister Pack Among Hypertensive Patients In Malaysia

    Nov 1, 2016, 00:00

  • Assessment of Proton Pump Inhibitors Consumption in Ukraine in Comparison with other Countries of The World

    Nov 1, 2016, 00:00

  • Products Outside the General Reimbursement Systems – A Swedish and Norwegian Comparison

    Nov 1, 2016, 00:00

  • Investigating The Perceptions Of The Greek Population Towards The Efficacy And Safety Of Generic Drugs

    Nov 1, 2016, 00:00

  • Budget Impact Model – Global Needs To Go Local

    Nov 1, 2016, 00:00

  • Optimal and Ensure Trials - Based Combined Cost-Effectiveness Analysis of Erlotinib Versus Chemotherapy for the First- Line Treatment of Asian Patients with Nonsquamous Non– Small-Cell Lung Cancer

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Diagnostics of Tuberculosis Infection in The Russian Federation with The Use of Tuberculous Recombinant Allergen

    Nov 1, 2016, 00:00

  • Assessment of Race-Specific Tolerability And Effectiveness of Exenatide once-Weekly or Basal Insulin Among Patients With Type 2 Diabetes In A Real World Setting In The USA

    Nov 1, 2016, 00:00

  • Health Care System Inefficiencies Related to Medicines- Any Potential Room for Improvement?

    Nov 1, 2016, 00:00

  • Application of Payment by Results Schemes in Oncology in Italy- Relation Between Timing for the Evaluation of Treatment Failures and Median Progression Free Survival (PFS) from Clinical Trials

    Nov 1, 2016, 00:00

  • Adding A Decision Aid to Asthma Education- Impact on Decisional Conflict and Appropriate Medication Usage

    Nov 1, 2016, 00:00

  • Criteria Used by German Pulmonologists for the Selection of an Inhaler

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Programs for Early Diagnostics of Refractive Errors for Children in Russia

    Nov 1, 2016, 00:00

  • A Systematic Review and Meta-Analysis To Access The Efficacy and Safety of Sorafenib in Advanced Hepatocellular Carcinoma (HCC)

    Nov 1, 2016, 00:00

  • Challenges in Economic Evaluations Conducted Alongside Clinical Trials of Schizophrenia- The Case of the Actions Study

    Nov 1, 2016, 00:00

  • Asians' Mental Health Status in a u.s. Midwestern metropolis, 2004 -2013

    Nov 1, 2016, 00:00

  • A Systematic Literature Review on the Efficacy-Effectiveness Gap- Comparison of Randomized Controlled Trials and Observational Studies of Glucose-Lowering Drugs

    Nov 1, 2016, 00:00

  • A Systematic Review Of Utilitiy Weights For Influenza And Influenza-Like Illness

    Nov 1, 2016, 00:00

  • Obstacles for Adoption of Value Added Medicines- Call for Policy Changes for Value Recognition of Repurposed Medicines

    Nov 1, 2016, 00:00

  • A Cost of Illness Study Evaluating The Healthcare And Societal Burden of Friedreich’s Ataxia In The United Kingdom

    Nov 1, 2016, 00:00

  • Evolutions In The Peer-Review Publication Landscape And Their Implications For Systematic Literature Reviews

    Nov 1, 2016, 00:00

  • Ongoing Analysis of Clinical and Economic Outcomes of Japanese Patients with Coronary Heart Disease Undergoing Percutaneous Coronary Intervention

    Nov 1, 2016, 00:00

  • Determination of Predictors of Prolonged Hospitalization among Dengue Patients Attending Tertiary Care Hospital in Malaysia

    Nov 1, 2016, 00:00

  • Cancer Concerns From US Medical And Pharmacy Directors 2016

    Nov 1, 2016, 00:00

  • Impact of Continuity of Care on Care And Costs For Chronic Disease

    Nov 1, 2016, 00:00

  • Pro Instruments for Mental Disorders Used in Studies Published Since 2005- Which Diseases have Had The Most Tools Developed?

    Nov 1, 2016, 00:00

  • Three Year Treatment Patterns of Ranibizumab and Aflibercept for The Management of Neovascular Age-Related Macular Degeneration in Routine Clinical Practice in The USA

    Nov 1, 2016, 00:00

  • Insights Into Early Stages of Alzheimer's Disease Using Claims Data

    Nov 1, 2016, 00:00

  • The Effect of Ras-Modifying Medications on Pulmonary Complications in Patients with Hypertension

    Nov 1, 2016, 00:00

  • Productivity Loss In Patients Diagnosed With Spinal Stenosis And Lumbar Disc Herniation

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Paritaprevir/Rotanavir/Ombitasvir with or without Dasabuvir in Ireland

    Nov 1, 2016, 00:00

  • Masters Degrees For Health Economists- Investigating And Evaluating Their Content

    Nov 1, 2016, 00:00

  • How to Maximise the Value and Payers’ Acceptance of Single Arm Trial Data in Oncology?

    Nov 1, 2016, 00:00

  • Association Between Insulin Treatment and Breast Cancer Characteristics

    Nov 1, 2016, 00:00

  • French Health Policies- Front Runner for Early Access to Innovation

    Nov 1, 2016, 00:00

  • Treatment Persistence with Golimumab in France

    Nov 1, 2016, 00:00

  • Medication Adherence And Risk Factors For Nonadherence Among Hiv Positive Pregnant Women Taking Tenofovir Based Fixed Dose Combination Regimen In Nigeria

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Endoscopic Treatment with Radiofrequency Ablation for Patients with Barrett's Esophagus and High Or Low Grade Dysplasia in Spain

    Nov 1, 2016, 00:00

  • Assessment of Decisions and Cost-Effectiveness Criteria Considered by Seven Health Technology Assessment Agencies

    Nov 1, 2016, 00:00

  • Inclusion Of Costs And Effects Related To Toxicity/Safety In Cost -Effectiveness Analysis; An Illustration For Influenza Vaccines

    Nov 1, 2016, 00:00

  • The Potential to Improve Inhalation Technique in Patients with Asthma Or Copd By Switching From Symbicort® Turbuhaler® (Budesonide + Formoterol) to Duoresp® Spiromax®- Estimated Impact on The Number and Cost of Unscheduled Healthcare Events ...

    Nov 1, 2016, 00:00

  • Market Uptake Of Direct Oral Anticoagulants (Doacs) In Germany

    Nov 1, 2016, 00:00

  • Economic Burden of Diseases In Poland

    Nov 1, 2016, 00:00

  • Cost Effectiveness of Sunitinib Versus Pazopanib and Best Supportive Care for the Treatment of Metastatic Renal Cell Carcinoma in Chile

    Nov 1, 2016, 00:00

  • A New Accelerated Early Access Process for Diagnostics in France

    Nov 1, 2016, 00:00

  • The Use of The Appraisal of Guidelines for Research and Evaluation Ii (AGREE II) Tool for Appraisal of Multiple Myeloma Treatment Guidelines

    Nov 1, 2016, 00:00

  • Development, Validation, and Pilot Testing of Metabolic Syndrome Quality of Life Questionnaire (Tapmetsqol)

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Restricted Protein Diet In Patients With Phenylketonuria In The Czech Republic

    Nov 1, 2016, 00:00

  • A Comparative Cost Analysis on Peritoneal Dialysis Versus Hemodialysis in Taiwan

    Nov 1, 2016, 00:00

  • Association Between Exposure To Anticholinergic And Sedative Drugs And Healthcare Costs In Elderly Patients With Cognitive Complaint

    Nov 1, 2016, 00:00

  • Health Economic Costing Methods and Reporting in Austria

    Nov 1, 2016, 00:00

  • Copd Uncovered- Health Care Resource Use and Cost of Chronic Obstructive Pulmonary Disease in Japan

    Nov 1, 2016, 00:00

  • Results From An on-Site Healthcare Provider Survey on Perceptions of Type 2 Diabetes Treatment

    Nov 1, 2016, 00:00

  • Efficacy and Safety of Panitumumab in Patients of Metastatic Colorectal Cancer By Tumor Kras Status- A Systematic Review

    Nov 1, 2016, 00:00

  • Faecal Calprotectin as A Diagnostic Marker of Inflammatory Bowel Disease in Patients with Gastrointestinal Symptoms - is It Cost-Effective Procedure in Primary Care in Poland?

    Nov 1, 2016, 00:00

  • Indirect Costs Of Epilepsy In Turkey- Cost Of The Disease In Terms Of Work Loss

    Nov 1, 2016, 00:00

  • Estimating the contribution on the reduction of the burden of iron deficiency anemia from the current fortification strategy of commercial foods targeted to infants and toddlers in india. Scenarios using systematic review and real world evi ...

    Nov 1, 2016, 00:00

  • Generic Drug Volume and Cost Savings in Oncology- A 2005-2014 Midas Analysis

    Nov 1, 2016, 00:00

  • Expert Elicitation- Can Variation In Elicited Distributions Be Explained By Expert Heterogeneity?

    Nov 1, 2016, 00:00

  • Determening The Optimal Price For New Non-Nucleoside Reverse Transcritase Inhbitor Using Early Economic Modeling

    Nov 1, 2016, 00:00

  • Estimating The Management Cost of HPV-Related Low-Grade and Precancerous High-Grade Lesions in France

    Nov 1, 2016, 00:00

  • The German Pain Practice Registry – A New Way to Use Real-Time Sampled Routine Data For Health-Care Research

    Nov 1, 2016, 00:00

  • Economic Evaluations of Haemophilus Influenzae Type B Vaccine- A Systematic Review

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Implementing Computed Tomography Screening for Early Diagnosis of Lung Cancer in Taiwan

    Nov 1, 2016, 00:00

  • Healthcare Resource Utilization and Costs Associated with Cardiovascular Events In Gree Results From A Delphi Panel

    Nov 1, 2016, 00:00

  • Cost Avoidance Of Pharmacist Running Pediatrics Total Parenteral Nutrition Services At Ministry Of Health In Saudi Arabia

    Nov 1, 2016, 00:00

  • Empirical Assessment of the Impact of Model Choice (Markov State Transition Versus Partitioned Survival) in Modelling Small-Cell Lung Cancer

    Nov 1, 2016, 00:00

  • Indirect Costs of Stroke in Turkey

    Nov 1, 2016, 00:00

  • Effect of Virus Hepatitis During Pregnancy on Maternal and Perinatal Adverse Outcomes- A Systematic Review Based on Observational Studies

    Nov 1, 2016, 00:00

  • Disease Related Knowledge, Medication Adherence And Glycaemic Control Among Patients With Type 2 Diabetes Mellitus In Pakistan

    Nov 1, 2016, 00:00

  • Multimorbidity and Health Care Service Utilization in the Australian Workfor Findings From the National Health Survey

    Nov 1, 2016, 00:00

  • Cost Effectiveness Analysis of A Flash Glucose Monitoring System for Type 1 Diabetes (T1DM) Patients Receiving Intensive Insulin Treatment in Europe and Australia

    Nov 1, 2016, 00:00

  • Design And Operational Considerations For Hybrid Retrospective-Prospective Studies

    Nov 1, 2016, 00:00

  • Oral Versus Intravenous Iron Treatment in Patients with Inflammatory Bowel Disease and Iron Deficiency and/or Anemia in Germany

    Nov 1, 2016, 00:00

  • Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention in Incident, Treatment-Naïve Non-Valvular Atrial Fibrillation

    Nov 1, 2016, 00:00

  • Health Expenditure By Disease Age And Gender In Greece

    Nov 1, 2016, 00:00

  • Effectiveness and Safety of Braf Inhibitors in The Treatment of Braf-Mutated Unresectable or Metastatic Melanoma- Real World Data

    Nov 1, 2016, 00:00

  • Missed Opportunities in The Netherlands- The Negligence of Non-Statistical Uncertainty in Ced Policy

    Nov 1, 2016, 00:00

  • Long-Term Health Care Cost in Patients with Symptomatic Peripheral Artery Disease- Results from a Swedish Nationwide Study

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Adding Novel or Group 5 Interventions To A Background Regimen For The Treatment of Multidrug-Resistant Tuberculosis In Germany

    Nov 1, 2016, 00:00

  • DB1 Mortality Excess Due To Clostridium Difficile Infection - A National Database Analysis

    Nov 1, 2016, 00:00

  • Pharmacoeconomic Analysis of Treatment of Children with Severe Uncontrolled Asthma with Omalizumab In Russia

    Nov 1, 2016, 00:00

  • Psychometric Evaluation Of The Revised Hiv Treatment Satisfaction Questionnaire (Hivtsq)

    Nov 1, 2016, 00:00

  • Comparison of Mortality Reduction From Gastric Cancer Among Different Screening Programs

    Nov 1, 2016, 00:00

  • Comparison of Oral Anti-Coagulants for Stroke Prevention in Non-Valvular Atrial Fibrillation- Two Multi-Criteria Decision Analyses

    Nov 1, 2016, 00:00

  • Exploring Interest in The Use of A Complementary Therapy Among Individuals With Copd

    Nov 1, 2016, 00:00

  • Estimation Of Value Of Life With A Model Approach Depending On Net Present Value For France, Germany, Italy, Spain And United Kingdom

    Nov 1, 2016, 00:00

  • Funding Expensive Drugs In Hospitals- Where Is France Going?

    Nov 1, 2016, 00:00

  • The use of a Dabigatran-Specific Reversal Agent- Budget Impact Analysis from the Hospital Perspective and the French Public Payer Perspective

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Sequential USE of ELF/ARFI Test Versus Biopsy to Assess Liver Fibrosis in Chronic HCV

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Insulin Degludec Compared with Insulin Glargine in the Management of Type 1 and Type 2 Diabetes Mellitus from the Spanish National Health System Perspective

    Nov 1, 2016, 00:00

  • 3 Year Clinical Effectiveness of Ranibizumab And Aflibercept For Neovascular AMD- A Retrospective Cohort Study Using Electronic Medical Records From The USA

    Nov 1, 2016, 00:00

  • Frequency, Impact and Health Care Costs of Infantile Hemangioma. Results of A Retrospective German Database Analysis

    Nov 1, 2016, 00:00

  • Self-Efficacy And Health Behaviors Impact Quality Of Life Of Elderly Along Eastern Sea Coast Of Thailand 2015

    Nov 1, 2016, 00:00

  • Costs of Multiple Myeloma Management And Treatment For Elderly Patients Who Are Not Transplant Candidates In The Serbian Health Care System

    Nov 1, 2016, 00:00

  • Biosimilars- Which Value For Society?

    Nov 1, 2016, 00:00

  • Description of First-Line Treatments in Patients with Non-Resectable Colorectal Cancers in Belgium

    Nov 1, 2016, 00:00

  • Soft Modelling Of Health-Related Quality Of Life Specific To Hiv In Relation To Anxiety, Depression, Personality Traits And Precariousness

    Nov 1, 2016, 00:00

  • Dispensing Patterns of Vaccines by Pharmacies in South Africa

    Nov 1, 2016, 00:00

  • Ovarcost Study- Economic Burden of Epithelial Ovarian Cancer in Spain

    Nov 1, 2016, 00:00

  • Drugs for Rare (And Ultra-Rare) Diseases in Europe- Analysis of Budget Impact and Cost Drivers

    Nov 1, 2016, 00:00

  • Clinical and Comparative Effectiveness of Telemonitoring Intervention Versus Usual Care For Type 2 Diabetes Mellitus- A Systematic Review and Meta-Analysis

    Nov 1, 2016, 00:00

  • Conceptual Model and Clinical Outcomes Assessments for Angelman’s Syndrome- Utilizing Pragmatic Methods in Rare Diseases

    Nov 1, 2016, 00:00

  • Complete Skin Clearance Is Not Attained By Most Patients Receiving Biologics For Moderate To Severe Plaque Psoriasis- Interim Results of An International, Prospective, Observational Study

    Nov 1, 2016, 00:00

  • Psychometric Properties and Measurement Equivalence of the English and Chinese Versions of the Beck Anxiety Inventory in Patients with Breast Cancer

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Panobinostat – Bortezomib and Dexamethasone, As 3rd Or 4th Line of Treatment in Patients with Relapsed/Refractory Multiple Myeloma in Greece

    Nov 1, 2016, 00:00

  • The Number Of Cases In Physiotherapy Services Within Specialized Home Care In Hungary Between 2010 And 2014

    Nov 1, 2016, 00:00

  • Instructions for Authors

    Nov 1, 2016, 00:00

  • Cost Per Response/Remission Across Biologics for the Treatment of Biologic Naïve Patients with Moderate-To-Severe Ulcerative Colitis from the Italian Healthcare Provider Perspective

    Nov 1, 2016, 00:00

  • Effectiveness and Safety of Vemurafenib as Monotherapy in Unresectable or Metastatic Melanoma from an Academic Database- Real World Data to Strengthen Evidence for Payer

    Nov 1, 2016, 00:00

  • Country Trends that May Impact the Commercial Opportunity of New High Cost Treatments in the USA, EU5, Japan and Brazil

    Nov 1, 2016, 00:00

  • Modelling Total Knee Replacement Surgery For Osteoarthritis in New Zealand- Validation of A Population-Based State-Transition Microsimulation Model

    Nov 1, 2016, 00:00

  • Web-Based Budget Impact Model Estimating Cost Savings of Dialysis Program in The UK

    Nov 1, 2016, 00:00

  • Do Pharmaceutical Cost Control Policies Effective In Reducing Pharmaceutical Expenditure And Volume? A Systematic Review

    Nov 1, 2016, 00:00

  • Health Technology Assessment Considerations of The Primary Care Model Programme

    Nov 1, 2016, 00:00

  • A Comparison of Euroqol EQ-5D And SF-36 for Estimating Health-Adjusted Life-Expectancy (HALE) in Taiwan

    Nov 1, 2016, 00:00

  • Impact of Generic Competition on Changes in Reference Price Per Ddd and Medicnes Utilization in the Group of Statins

    Nov 1, 2016, 00:00

  • Health State Valuation in Sri Lanka Using the EQ-5D-3l; Precursor to Qaly Estimation in South Asia

    Nov 1, 2016, 00:00

  • Translatability Evaluation of the Rome IV Diagnostic Questionnaire for Adults

    Nov 1, 2016, 00:00

  • Direct and Indirect Costs Associated with Legal Blindness Caused by Retinal Disorders in Brazil

    Nov 1, 2016, 00:00

  • Budget Impact of Apremilast For Active Psoriatic Arthritis In The UK

    Nov 1, 2016, 00:00

  • Accelerated/Malignant Hypertension with a Diagnostic Ambugity- A Retrospective Cohort Study

    Nov 1, 2016, 00:00

  • Iron Deficiency Anemia In Pregnant Women In Fran A Prospective Cohort Study

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Using Procalcitonin-Based Antibiotics Stewardship for Community Acquired Pneumonia

    Nov 1, 2016, 00:00

  • Tyrosine Kinase Inhibitors (TKI) For The Treatment of Advanced Medullary Thyroid Carcinoma- A Systematic Review and Indirect Comparison

    Nov 1, 2016, 00:00

  • Determinants of Orphan Drug Prices in Italy and the UK

    Nov 1, 2016, 00:00

  • Cost-Utility of Prophylaxis VS. On-Demand Treatment In Severe Haemophilia A Patients

    Nov 1, 2016, 00:00

  • Quinolones Utilization in Two Tertiary Hospitals in Nigeria; A Pharmacoepidemiological Survey

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Nanoliposomal Irinotecan for Treatment of Pancreatic Cancer Following Progression on Gemcitabine - A Us Payer Perspective

    Nov 1, 2016, 00:00

  • Consolidation of China's Two Basic Medical Insurance Programs- Understanding New Opportunities for Access

    Nov 1, 2016, 00:00

  • Prescribing Patterns of Opioids Dispensed by Pharmacies in South Africa

    Nov 1, 2016, 00:00

  • Knowledge, Attitude And Perception Of Zika Virus Among Healthcare Students Of Medicine, Pharmacy And Dentistry Of Aimst University

    Nov 1, 2016, 00:00

  • Cost-Analysis for Toxicity Management in Advanced Squamous Non-Small Cell Lung Cancer- Nivolumab vs Docetaxel

    Nov 1, 2016, 00:00

  • Multi-Criteria Assessment In HTA Process in the Czech Republic- the Role of Different Stakeholders Involvement and Impact on Appraisal of Drugs Including Orphans

    Nov 1, 2016, 00:00

  • Comparison Of Estimated Effectiveness Of Biologics For Rheumatoid Arthritis (Ra) In Large Insurance Databases Using A Claims-Based Algorithm

    Nov 1, 2016, 00:00

  • Economic Evaluation of Pertuzumab In Combination with Trastuzumab and Docetaxel in the Neoadjuvant Treatment of Women with HER2-Positive, Locally Advanced, Inflammatory or Early Breast Cancer in Portugal

    Nov 1, 2016, 00:00

  • Review of Pricing Taiwan

    Nov 1, 2016, 00:00

  • Need for Enhanced Glucose Screening in Pregnant Women in Indonesia

    Nov 1, 2016, 00:00

  • Risk and Burden of Subsequent Fractures After First Osteoporosis-Related Fracture Among Osteoporosis Patients in Tianjin, China

    Nov 1, 2016, 00:00

  • Interactive Health Economic Models Configured With Google Analytics. Data And Metrics Applicable For A Healthcare Research

    Nov 1, 2016, 00:00

  • Second Medical Opinion- Utilization Rates And Characteristics of Seekers In A General Population

    Nov 1, 2016, 00:00

  • Understanding the Impact of Laboratory Performance on Outcomes in a Screening Population for Cardiovascular Disease in Taiwan

    Nov 1, 2016, 00:00

  • Estimating the Appropriate Price Discounts for Biosimilars in the Treatment of Rheumatoid Arthritis in the Nordic Setting Using an Excel-Based Interactive Tool

    Nov 1, 2016, 00:00

  • Knowledge, Attitudes and Practices of Cervical Cancer Screening Among Women Attending A Childhood Immunization Clinic in Uganda

    Nov 1, 2016, 00:00

  • Pretesting An E-Based Version Of The Oxford Participation Activities Questionnaire (Ox-Paq)

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Evaluation of Acarizax® In Patients with House Dust Mites Induced Allergic Asthma And Allergic Rhinitis In Slovakia

    Nov 1, 2016, 00:00

  • How Much Does An Asthma-Related Event Cost In A Malaysian Suburban Hospital?

    Nov 1, 2016, 00:00

  • Budget Impact of Switching From an Extended-Release to an Immediate-Release Formulation of Tacrolimus in Renal Transplant Recipients in Spain

    Nov 1, 2016, 00:00

  • Title- Access to Orphan and Ultra-Orphan Drugs in China

    Nov 1, 2016, 00:00

  • Psoriatic Arthritis is Associated with A Greater Economic and Humanistic Burden Among Patients with Psoriasis- Results from A Multinational Physician and Patient Survey

    Nov 1, 2016, 00:00

  • Implementation of Adverse Event Trigger Tool System for Assessing Patient Safety

    Nov 1, 2016, 00:00

  • Has Pharmaceutical Innovation Increased Persistence and Adherence of Multiple Sclerosis Patients in Germany?

    Nov 1, 2016, 00:00

  • Does The Trend Towards Value Frameworks Require New Approaches to Evidence Development and Health Technology Assessment?

    Nov 1, 2016, 00:00

  • Use of Data-Mining to Perform a Real World Cost Analysis of Her2-Positive Breast Cancer In Iran

    Nov 1, 2016, 00:00

  • Multithreading- Turbocharged Cost-Effectiveness Analyses in Microsoft Excel

    Nov 1, 2016, 00:00

  • Patient Reported Outcomes In Japanese Oncology Products - Review Of The Pmda Labels

    Nov 1, 2016, 00:00

  • Hospital Admissions and Inpatient Costs of Non-Union, Delayed Union and Mal-Union Following Long Bone Fracture

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Evolocumab in Patients with High Cardiovascular Risk in Spain

    Nov 1, 2016, 00:00

  • Bariatric Surgery Versus Non-Surgical Treatment of Morbid Obesity- A Systematic Review

    Nov 1, 2016, 00:00

  • Renal Anemia Treatment in the Us- How Payer Policies and Physician Preferences Drive Prescribing and How will the Emerging Oral HIF-PH Inhibitors Influence Payers and Physicians?

    Nov 1, 2016, 00:00

  • Influence of Air Pollution on Some Pregnancy Outcomes and Burden of Pneumonia on Children Under Five Years Old in Mongolia

    Nov 1, 2016, 00:00

  • What is the Most Cost-Effective Way to Set-Up Organised Cervical Cancer Screening in France? A Cost-Effectiveness Analysis

    Nov 1, 2016, 00:00

  • Identifying Potential Early Biomarkers Of Acute Myocardial Infarction In The Biomedical Literature- A Comparison Of Text Mining And Manual Sifting Techniques

    Nov 1, 2016, 00:00

  • The Economic Burden of Fibromyalgia in Japan

    Nov 1, 2016, 00:00

  • The Budget Impact Analysis of Thrombopoietin Receptor Agonists For The Treatment of Idiopathic Thrombocytopenic Purpura In Adults

    Nov 1, 2016, 00:00

  • Trend Of Pharmacoeconomics And Health Outcome Studies In Turkey

    Nov 1, 2016, 00:00

  • Estimating the Economic Burden of Heart Failure Patients in Korea

    Nov 1, 2016, 00:00

  • Relationship between Perception of Sex Hormones Imbalance, Depression and Cognitive Function among Female Students in International Medical University- A Cross-Sectional Study

    Nov 1, 2016, 00:00

  • Real-World Evidence in the Context of Hta- On the Example of Uterine Fibroids Treatment in Ukraine

    Nov 1, 2016, 00:00

  • Real-World Comorbidities, Treatment Pattern and Cost of Patients with Acromegaly in Poland Based on Retrospective Analysis Of Administrative Claims Data

    Nov 1, 2016, 00:00

  • Viewpoints of Thalassaemia Patients on the Combination of Traditional CM) with the Conventional Thalassaemia Treatment-A Qualitative Understanding Approach

    Nov 1, 2016, 00:00

  • Market Uptake Models Of Biosimilars And Off-Patent Biological Medicines

    Nov 1, 2016, 00:00

  • How do Cost-Containment Measures Impact Pharmaceutical Industry?

    Nov 1, 2016, 00:00

  • The Cost of Hypercholesterolaemia in Ireland

    Nov 1, 2016, 00:00

  • Horizontal and Vertical Financial Equity in Hospitalized Cardiovascular Patients; A Case Study in Iran

    Nov 1, 2016, 00:00

  • Insights for Care- The Healthcare Utilisation and Cost Impact of Managing Diabetes-Associated Nephropathy and Neuropathy at a UK Secondary Care Hospital

    Nov 1, 2016, 00:00

  • Cost of Switching From An Originator Biologic (Remicade) To A Biosimilar

    Nov 1, 2016, 00:00

  • Burden of Visual Impairment Due to Myopic Choroidal Neovascularisation (MCNV) in Turkey

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Population Screening for Haemochromatosis In Australia- A State-Transition Model

    Nov 1, 2016, 00:00

  • A Cost-Consequence Analysis of Parecoxib Plus Opioids Versus Opioids Alone In The Management of Postoperative Pain In China

    Nov 1, 2016, 00:00

  • Assessment of Knowledge, Attitude and Barriers Towards ADRS Reporting Among Healthcare Professionals of Abbottabad, Pakistan

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Colorectal Cancer Screening in Austria and Assessment of The Impact of Cancer-Causing Risk Factors

    Nov 1, 2016, 00:00

  • Evaluate the Cost-Effective Threshold of Osteoporosis Treatment on Elderly Women in China Using Discrete Event Simulation Model

    Nov 1, 2016, 00:00

  • The Use Of Administrative Data To Determine Prevalence And Incidence Of Copd- A Systematic Review

    Nov 1, 2016, 00:00

  • Cost–Effectiveness of Different Strategies for Prevention of Venous Thromboembolism after Total Hip Replacement in China

    Nov 1, 2016, 00:00

  • Cost-Benefit Analysis for Direct Visual Observation of Nasogastric Enteral Feeding Tube Placement

    Nov 1, 2016, 00:00

  • Lipid Levels and Glycaemic Control in Malaysian Diabetes Patients

    Nov 1, 2016, 00:00

  • Early Market Access for Pharmaceuticals in EU- What is the Impact of Ema’s Accelerated Assessment Procedure?

    Nov 1, 2016, 00:00

  • Effects of A Chronic Obstructive Pulmonary Disease Integrated Care Pathway Programme in Singapore

    Nov 1, 2016, 00:00

  • A Prospective Assessment of Attitudes and Experiences Among Urologists Regarding off Label Use of BCG Vaccine in Serbia

    Nov 1, 2016, 00:00

  • Trends in Research Using Observational Methodologies in Chronic Lymphocytic Leukemia (CLL)- A Systematic Literature Review

    Nov 1, 2016, 00:00

  • Network Meta-Analysis Comparing Palbociclib with Chemotherapies For Treatment of Postmenopausal Women With HR+/ HER2- Advanced/ Metastatic Breast Cancer

    Nov 1, 2016, 00:00

  • Comparison Between Eq-5d And Hui In Japanese Population Norms

    Nov 1, 2016, 00:00

  • Evaluating Socio-Demographic Characteristics Of Patients In The United States Department Of Defense Population

    Nov 1, 2016, 00:00

  • Health Outcomes Related to Legal Blindness Caused By Retinal Disorders in Brazil

    Nov 1, 2016, 00:00

  • Development of a Mapping Algorithm Between the SGRQ and EQ-5D-5L Utility Values in a Severe Asthma Population

    Nov 1, 2016, 00:00

  • Future Disparities Between Demand And Supply of Tertiary Emergency Care In Regions Affected By The Great East Japan Earthquake

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Insulin Degludec Treatment in Patients with Type1 and Type 2 Diabetes Mellitus- A Systematic Review

    Nov 1, 2016, 00:00

  • Presence of Lipohypertrophy and its Relation to Insulin Injection Practices in Patients with Type 1 Diabetes Mellitus

    Nov 1, 2016, 00:00

  • Participation Of External Medical Societies In The Benefit Assessment Of Pharmaceuticals In Germany

    Nov 1, 2016, 00:00

  • Patient Perspectives on Merkel Cell Carcinoma (MCC) and Its Treatment with A Novel Agent (AVELUMAB)- Findings From In-Depth Qualitative Patient Interviews

    Nov 1, 2016, 00:00

  • Guidelines for Translation and Cross-Cultural Adaptation of Non-Technical Skills Rating Instruments

    Nov 1, 2016, 00:00

  • The Economic Burden of Hepatitis C In France And Romania

    Nov 1, 2016, 00:00

  • A Prospective Study of Antihypertensive Drugs Utilization Pattern in Outpatients of a Tertiary Care Teaching Hospital

    Nov 1, 2016, 00:00

  • Predictors of Disease Progression in Mild Alzheimer’s Disease Dementia Patients – Results From the Geras Real World Cohort and Expedition Trials

    Nov 1, 2016, 00:00

  • How Does the Additional Benefit Extend of Orphan Drugs Impact Price Negotiations in the German Outpatient Sector?

    Nov 1, 2016, 00:00

  • Validity of Child Health-6 Dimension(CH-6D) for Adolescents

    Nov 1, 2016, 00:00

  • Spiralling Healthcare Expenditure in Malaysia- Is it Sustainable?

    Nov 1, 2016, 00:00

  • Budget Impact Associated With The Implementation Of A Dtpa-Ipv-Hepb/Hib Hexa Vaccination Program In Slovenia

    Nov 1, 2016, 00:00

  • Arbitration Board Setting Reimbursement Amounts For Pharmaceutical Innovations In Germany When Price Negations Between Payors And Manufacturers Fail- An Empirical Analysis Of 5 Years' Experience

    Nov 1, 2016, 00:00

  • Estimated Costs of Locoregional and Metastatic Recurrences in Patients with HER2+ Breast Cancer in Spain

    Nov 1, 2016, 00:00

  • The Association with Psychiatric Diseases and Patients with Chronic Spontaneous Urticaria in Taiwan

    Nov 1, 2016, 00:00

  • A Comparison of Insulin Degludec Clinical Evaluations and Recommendations Between an Independent HTA and National HTA Bodies

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Of Recombinant Human Follicle Stimulating Hormone Biosimilars In Portugal

    Nov 1, 2016, 00:00

  • Clinical And Economic Impact of Treatment-Free Interval In Patients With Relapsed/Refractory Multiple Myeloma

    Nov 1, 2016, 00:00

  • Assessing the Gap Between Prioritized Conditions and Covered Conditions in Current Legislation for Rare and Orphan Diseases in Peru

    Nov 1, 2016, 00:00

  • Identifying Patient Reported Signs and Symptoms of Being Overweight and Obese

    Nov 1, 2016, 00:00

  • The Choice of A Fluoropyrimidine Regimen in Patients with Advanced Colorectal Cancer

    Nov 1, 2016, 00:00

  • Pay For Performan A Proposal For And Simulation Of Real Time Outcomes-Based Pharmaceutical Pricing Using Routinely Collected Data

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Using Brentuximab Vedotin in Patients with Recurrent Hodgkin Lymphoma or Refractory to Transplant

    Nov 1, 2016, 00:00

  • Creating Useful and Comprehensive Decision Support Tools for Selecting and Designing Managed Entry Agreements

    Nov 1, 2016, 00:00

  • Construction of System Dynamics Model for Medical Care System of Japan

    Nov 1, 2016, 00:00

  • The Cost-Effectiveness of Ketoconazole Versus Metyrapone for the Treatment of Cushing’s Syndrome in a Swedish Setting

    Nov 1, 2016, 00:00

  • The Impact of Extrapolating Survival Based on Cure Models- Comparing Mean Incremental Survival and Cure Rates in Different Datasets

    Nov 1, 2016, 00:00

  • Assessment of Health Related Quality of Life (Hrqol) of Patients with Severe Mental Illness Attending Tertiary Care Public Hospitals of Quetta, Pakistan

    Nov 1, 2016, 00:00

  • Patient Information And Consent Form In Europe- Requirements From Regulatory Authorities For Pharmaco-Epidemiological Studies

    Nov 1, 2016, 00:00

  • Impact of Initiation of Long-Acting Injectable Antipsychotics on Resource Utilization In Patients with Schizophrenia

    Nov 1, 2016, 00:00

  • Is There A Difference In Perception And Practice In Pharmacological Management Of Schizophrenia- A Cross Sectional Survey In India

    Nov 1, 2016, 00:00

  • Variation in the Number and Type of Heart Valve Procedures Performed in the UK – Is Patient Access Equitable?

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Sucroferric Oxyhydroxide in Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease

    Nov 1, 2016, 00:00

  • Trends in Health Technology Assessments since the Introduction of Cost-Effectiveness in the Netherlands

    Nov 1, 2016, 00:00

  • A Propensity Score Matched Study of Plasmablade Vs Coblation Technology During Pediatric Tonsillectomy and Adenoidectomy Procedures

    Nov 1, 2016, 00:00

  • ND1 Burden And Work Productivity Loss Impairment From Providing Care To Alzheimer's Disease Patients

    Nov 1, 2016, 00:00

  • The Economic Burden of Heart Failure in Latin America

    Nov 1, 2016, 00:00

  • Prediction of the Morbidity with Bacterial Purulent Meningitis of Various Origin with Consideration of the Existing Vaccine Prevention Procedures

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of National Cervical Cancer Screening Program in Denmark- Cytology with HPV triage vs. HPV Primary Screening with Reflex Cytology Triage Cintec Plus Cytology

    Nov 1, 2016, 00:00

  • How To Ensure An Efficient Resource Allocation For The Treatment of Chronic Myeloid Leukemia

    Nov 1, 2016, 00:00

  • Iatrogenic Hypoglycaemia in the Elderly- An Analysis of Diabetic Medication Usage Patterns According to Age

    Nov 1, 2016, 00:00

  • A Cost-Effectiveness Analysis of Guanfacine Extended-Release Treatment in Pediatric Attention-Deficit/Hyperactivity Disorder

    Nov 1, 2016, 00:00

  • assessment Of Willingness To Pay For Consultaion And Diagnostic Services In Sheikh Khalifa Bin Zayyed Al-Nayyan Medical Complex, Quetta

    Nov 1, 2016, 00:00
  • «
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78 (current)
  • 79
  • 80
  • »